September 30, 2016 Bio/Pharma/CRO Licensing, IP, and Legal Product Launch

GE Healthcare’s Biosafe announces Sefia platform to address multiple steps in cell therapy production process

CHALFONT ST. GILES, UK – 30 September 2016 –At the International Society for Cellular Therapy’s Regional Meeting in Memphis, TN, GE Healthcare’s recently acquired Biosafe Group introduces Sefia, a state-of-the-art, multi-function platform which uses a combination of continuous-flow centrifugation, temperature control and fluidic management to enable purification, concentration, washing  and final formulation during cell processing. Combined with GE... Read more

September 29, 2016 Cell Analysis Tools Licensing, IP, and Legal

Miltenyi Biotec acquires exclusive rights for the distribution and development of the viral transduction enhancer Vectofusin-1® from Genethon

Evry, France, and Bergisch Gladbach, Germany, September 28th, 2016 – Genethon, a leader in the field of gene therapy treatments for rare diseases, and Miltenyi Biotec, a global front-runner in cell processing and related technologies in cell therapy, have announced the execution of an exclusive license to the patents and trademarks for the development and commercialization... Read more

September 29, 2016 Bio/Pharma/CRO Product Launch

GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea

Chalfont St. Giles, UK and Songdo, Korea – 29 September 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, announced today the opening of a GE Fast Trak Center in Songdo, Incheon Metropolitan City, South Korea. The new USD 7.4 million Center will... Read more

September 29, 2016 Environ, Ag./Food & Bev PR/Corporate Product Launch

New, reliable and affordable method for glyphosate analysis presented

Metrohm is pleased to present an application for the straightforward determination of the herbicide glyphosate and its primary metabolite AMPA in drinking water by ion chromatography with pulsed amperometric detection. With a detection limit of approximately 1 µg/L, the method is sensitive enough to comply with limit values in the US, Canada, Australia, and others.... Read more

September 28, 2016 Clinical Research/Diagn. Product Launch

Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases

Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases MADISON, WIS, September 28, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company and the leading developer and manufacturer of induced pluripotent stem cell (iPSC) products, today announced a new venture, named Opsis Therapeutics. Formed on July 31, Opsis Therapeutics... Read more

September 22, 2016 Cell Analysis Tools Product Launch

Cellular Dynamics Announces Launch of iCell® Hepatoblasts to Enable Research into Therapies That Stimulate Liver Regeneration

MADISON, Wis., September 22, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced the launch of iCell® Hepatoblasts, liver progenitor cells generated from human induced pluripotent stem cells (iPSCs). These cells show promise for liver regeneration therapy research by enabling researchers to identify molecules capable of stimulating liver progenitor cell proliferation and... Read more

September 22, 2016 Bio/Pharma/CRO M&A, Partnerships Product Launch

See. Click. Send. New Cloud-based Ultrasound Solution Enables Instant, Enhanced Collaboration Among Clinicians

Rome – 22 September 2016 – GE Healthcare and Trice Imaging, Inc., a cloud-based medical imaging solutions provider, today announced a commercial partnership to provide a new way for clinicians to connect with their colleagues and patients. This solution – called Tricefy™ – adds cloud-based image sharing, diagnostic collaboration, remote reviewing, archiving and Electronic Health Record... Read more

September 22, 2016 Uncategorized

R-Pharm produces biological drugs in Yaroslavl with GE Healthcare’s FlexFactory™ manufacturing platform

CHALFONT ST. GILES, UK and YAROSLAVL, RUSSIA – 22 September 2016 –  R-Pharm Group has opened an innovative biopharmaceutical production plant equipped with GE Healthcare’s FlexFactory™ manufacturing platform in Yaroslavl, Russia. R-Pharm’s FlexFactory will support the mass production of biologics and biosimilars focused on treating autoimmune diseases and cancer, and allowing for increased access to these... Read more

September 22, 2016 Bio/Pharma/CRO Product Launch

R-Pharm produces biological drugs in Yaroslavl with GE Healthcare's FlexFactory™ manufacturing platform

CHALFONT ST. GILES, UK and YAROSLAVL, RUSSIA – 22 September 2016 –  R-Pharm Group has opened an innovative biopharmaceutical production plant equipped with GE Healthcare’s FlexFactory™ manufacturing platform in Yaroslavl, Russia. R-Pharm’s FlexFactory will support the mass production of biologics and biosimilars focused on treating autoimmune diseases and cancer, and allowing for increased access to these... Read more